Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY

(HZNP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Horizon Therapeutics plc Makes $100,000 Seed Donation to Support Fundraising Efforts to Renovate Emmett Till's Home into a Museum and Theater

12/03/2021 | 08:26am EST

DEERFIELD, Ill. - Horizon Therapeutics plc (Nasdaq: HZNP) announced it has made a $100,000 seed donation to promote community engagement around the renovation of Emmett Till's childhood home in Chicago'sWest Woodlawn neighborhood.

The Till-Mobley Great Migration House Museum, Theatre & Garden will focus on educating patrons about the movement of seven million Blacks from the Jim Crow south to northern cities, which they transformed through hard work and enriched with heritage traditions. One such tradition was sending their children back to the south to visit family for the summer. Till, a 14-year old Black child from Chicago on a summer visit to Mississippi, was murdered after being accused of offending a white woman in her family's grocery store. His mother, Mamie Till-Mobley laid his body to rest in an open-casket funeral to broadcast the horrors of race hate, and America's civil rights movement was born.

'Living the values of diversity, equity and inclusion begins with dialogue and understanding,' said Irina Konstantinovsky, chief human resources office and chief diversity officer, Horizon. 'Horizon became involved with the restoration of the Emmett Till House through a group of our Black employees who were looking for ways the company could support the Black community and create an authentic space where historically marginalized voices could be amplified. We are proud to lend support to an institution that will help teach current and future generations about a pivotal time in American history while simultaneously helping to eradicate racism.'

The renovation will be led by Blacks In Green (BIG), a Chicago-based organization dedicated to reinventing the African American 'walk-to-work, walk-to-shop, walk-to-learn, walk-to-play' village made common during the Great Migration. Blacks In Green purchased the two-flat home last year and the Chicago City Council granted the home historical landmark status in January 2021. The non-profit is actively seeking additional supporters and sponsors for development of the Till-Mobley home, and just received City of Chicago Adopt-a-Landmark funding to begin exterior restoration.

'The restoration of Emmett Till's home is essential to our efforts to preserve his memory and legacy here in Chicago and the Woodlawn community,' said Chicago Mayor Lori E. Lightfoot. 'I want to thank Horizon Therapeutics and Blacks In Green for working together to turn this landmark into a space for learning, listening and addressing racism and other inequities.'

'We aim to transform the Emmett and Mamie Till-Mobley home into an international heritage destination that celebrates America's Great Migration Story of courage, fortitude, creativity, labor and love that built our great American cities,' said Naomi Davis, founder, Blacks In Green. 'With Horizon's support, the Emmett Till House will become a vital source of pride for West Woodlawn and Chicago.'

About Blacks In Green

Blacks In Green, a Chicago-based nonprofit focused on connecting communities and their stakeholders in the design and development of green, self-sustaining, mixed-income, walkable-villages in communities owned and populated by African Americans. The preservation of The Emmett Till House will serve the community and as a place of pilgrimage of social and racial justice. For more information, visit Home | Glrbig (blacksingreen.org)

About Horizon

Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives.

Contact:

Geoff Curtis

Executive Vice President

Corporate Affairs & Chief Communications Officer

E: media@horizontherapeutics.com

(C) 2021 Electronic News Publishing, source ENP Newswire

All news about HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
09:52aHorizon Therapeutics Enrolls First Patient in Trial of Idiopathic Pulmonary Fibrosis Tr..
MT
08:23aHorizon Therapeutics plc Announces First Patient Enrolled in Phase 2b Pivotal Trial Eva..
BU
01/11Horizon Therapeutics plc Submits Supplemental Biologics License for the Concomitant Use..
AQ
01/10Horizon Therapeutics Seeks to Expand Indication for Uncontrolled Gout Medicine Krystexx..
MT
01/10Horizon Therapeutics plc Submits Supplemental Biologics License for the Concomitant Use..
BU
01/062022 Could be a Banner Year for Biotech Stocks as per top managers (SPRC, HOTH, NLSP, P..
AQ
01/06Horizon Therapeutics plc Announces Significant Expansion of East Coast Research and Dev..
BU
01/06Horizon Therapeutics plc Announces Significant Expansion of East Coast Research and Dev..
CI
2021Horizon Therapeutics plc to Participate in Upcoming Investor Conferences
BU
2021Horizon Therapeutics Working With Alpine Immune Sciences to Develop Therapies for Autoi..
MT
More news
Analyst Recommendations on HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
More recommendations
Financials (USD)
Sales 2021 3 200 M - -
Net income 2021 542 M - -
Net Debt 2021 1 151 M - -
P/E ratio 2021 58,0x
Yield 2021 -
Capitalization 19 602 M 19 602 M -
EV / Sales 2021 6,49x
EV / Sales 2022 4,91x
Nbr of Employees 1 805
Free-Float 97,8%
Chart HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
Duration : Period :
Horizon Therapeutics Public Limited Company Technical Analysis Chart | HZNP | IE00BQPVQZ61 | MarketScreener
Technical analysis trends HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 86,42 $
Average target price 141,33 $
Spread / Average Target 63,5%
EPS Revisions
Managers and Directors
Timothy P. Walbert Chairman, President & Chief Executive Officer
Paul W. Hoelscher Chief Financial Officer & Executive Vice President
Jeffrey W. Sherman CMO, Executive VP-Development & Regulatory Affairs
Jeffrey D. Kent Executive VP-Medical Affairs & Outcomes Research
Karin Rosen Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY-19.80%19 602
JOHNSON & JOHNSON-3.62%434 036
ROCHE HOLDING AG-4.87%319 830
PFIZER, INC.-10.60%296 303
ABBVIE INC.-2.53%233 325
ELI LILLY AND COMPANY-12.00%220 356